Studies find AI helps developers release more software—while logging longer hours and fixing problems after the code goes ...
For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could ...
News-Medical.Net on MSN
Leading CROs and CDMOs turn to mass photometry for rapid protein, mRNA and viral vector analytics
Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research ...
The launch coincides with a crucial shift in the hiring landscape. TestGorilla co-founder and CEO Wouter Durville shared data at the event highlighting this change: 70% of companies now report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results